Related Experiment Video
Updated: Dec 7, 2025

Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis
Published on: March 15, 2024
COVID-19 Related Mortality During Management of a Hepatic Abscess
Robert Elliott1, Nana Ohene Baah2, Valerie Aarne Grossman3
1Imaging Sciences, University of Rochester, Rochester, New York.
Insights
This case study emphasizes infection control during the COVID-19 pandemic. Effective strategies are crucial for limiting the spread of SARS-CoV-2 in hospitals.
Area of Science:
- Infectious Diseases
- Public Health
- Epidemiology
Background:
- The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, China, led to the global coronavirus disease (COVID-19) pandemic.
- The World Health Organization declared COVID-19 a pandemic on March 11th, 2020, placing immense strain on healthcare systems worldwide.
- Limiting the transmission of both community-acquired and hospital-acquired infections became a critical challenge for healthcare facilities.
Observation:
- A patient case is presented from a Level I affiliated community hospital in Western New York during a peak SARS-CoV-2 surge.
- The case highlights the practical challenges and critical importance of maintaining robust infection control measures.
- Observations focus on the hospital environment during a period of high patient volume and viral transmission.
Findings:
- The case underscores the necessity of stringent infection control protocols to prevent SARS-CoV-2 transmission.
- Effective implementation of infection control practices is vital for patient safety and healthcare worker protection.
- The study emphasizes the role of infection control in mitigating the impact of viral surges within hospital settings.
Implications:
- Reinforces the critical role of infection control in managing infectious disease outbreaks like COVID-19.
- Provides practical insights for hospitals on adapting and reinforcing infection control measures during pandemic conditions.
- Suggests the need for continuous evaluation and improvement of infection control strategies to combat emerging infectious threats.
Abstract:
The coronavirus disease (COVID-19) is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which originated in the capital city of the Hubei Province, Wuhan, China, in late 2019. Declared a pandemic by the World Health Organization on March 11th, 2020, COVID-19 has challenged healthcare systems to limit the spread of community and hospital-acquired disease. This article uses a patient case to highlight the importance of infection control during the height of the SARS-CoV-2 surge at a Level I affiliated community hospital in Western New York.
Related Concept Videos
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Acute Pancreatitis II: Clinical Manifestations and Management
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pyelonephritis II: Diagnostic Studies and Management
Myocarditis III: Medical Management

